Prevention of complications related to traumatic brain injury in children and adolescents with creatine administration: An open label randomized pilot study

Journal of Trauma - Injury, Infection and Critical Care

Volumn 61, Issue 2, 2006, Pages 322-329

  Sakellaris, G ^a,c   Kotsiou, M ^b   Tamiolaki, M ^b   Kalostos, G ^a   Tsapaki, E ^a   Spanaki, M ^a   Spilioti, M ^a   Charissis, G ^a   Evangeliou, A ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b Aristotle University of Thessaloniki   (Greece)

^c NONE   (Greece)

Author keywords

Creatine; Outcome; Pediatric; Traumatic brain injury

Indexed keywords

CREATINE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ARTICLE; BRAIN INJURY; CALCIUM HOMEOSTASIS; CHILD; CHILDHOOD INJURY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HEAD INJURY; HIGH RISK PATIENT; HUMAN; MALE; NEUROPROTECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SELF CARE;

ADOLESCENT; BRAIN INJURIES; CHILD; CHILD, PRESCHOOL; CREATINE; HUMANS; INFANT; NEUROPROTECTIVE AGENTS; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 33747585833     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/01.ta.0000230269.46108.d5     Document Type: Article

References (25)

1. Tegas JJ 3rd, DiScala C, Ramenofsky MC, Barlow B. Mortality and head injury: the pediatric perspective. J Pediatric Surg. 1990;25:92-96.
2. Sullivan G, Geiger JD, Mattson MP, Scheff SW. Dietary supplement creatine protects against traumatic brain injury. Ann Neurol. 2000;48:723-729.
3. Scheff SW, Dhillon HS. Creatine-enhanced diet alters levels of lactate and free fatty acids after experimental brain injury. Neurochem Res. 2004;29:469-479.
4. Gasparovic C, Arfai N, Smid N, Feeney DM. Decrease and recovery of N-acetylaspartate/creatine in rat brain remote from focal injury. J Neurotrauma. 2001;18:241-246.
5. Stockler S, Marescau B, De Deyn PP, Trijbels JM, Hanefeld F. Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis. Metabolism. 1997;46:1189-1193.
6. Schulze A, Bachert P, Schlemmer H, et al. Lack of creatine in muscle and brain in an adult with GAMT deficiency. Ann Neurol. 2003;53:248-251.
7. Tarnopolsky MA, Roy BD, MacDonald JR. A randomized controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve. 1997;20:1502-1509.
8. Bachmann C, Braissant O, Villard AM, Boulat O, Henry H. Ammonia toxicity to the brain and creatine. Mol Genet Metab. 2004;81(Suppl 1):S52-S57.
9. Berger R, Middelanis J, Vaihinger HM, Mies G, Wilken B, Jensen A. Creatine protects the immature brain from hypoxic-ischemic injury. J Soc Gynecol Investig. 2004;11:9-15.
10. Balestrino M, Rebaudo R, Lunardi G. Exogenous creatine delays anoxic depolarization and protects from hypoxic damage: dose-effect relationship. Brain Res. 1999;816:124-130.
11. Felber S, Skladal D, Wyss M, Kremser C, Koller A, Sperl W. Oral creatine supplementation in Duchenne muscular dystrophy: a clinical and 31P magnetic resonance spectroscopy study. Neurol Res. 2000;22:145-150.
12. Gordon A, Hultman E, Kaijser L, et al. Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. Cardiovasc Res. 1995;30:413-418.
13. Holtzman D, Togliatti A, Khait I, Jensen F. Creatine increases survival and suppresses seizures in the hypoxic immature rat. Pediatr Res. 1998;44:410-414.
14. Thornhill S, Teasdale G, Murray G, McEwen J, Roy C, Penny K. Disability in young people and adults one year after head injury: prospective cohort study. Br Med J. 2000;320:1631-1635.
15. Berger M, Pitts L, Lovely M, Edwards M, Bartkowski H. Outcome from severe head injury in children and adolescents. J Neurosurg. 1985;62:194-199.
16. Costeff H, Groswasser Z, Goldstein R. Long term follow up review of 31 children with severe closed head trauma. J Neurosurg. 1990;73:684-687.
17. Jennett B, Snoek J, Bond MR. Disability after severe head injury: observations on the use of the Glasgow outcome scale. J Neurol Neurosurg Psyhiatry 1981;44:285-293.
18. Rappaport M, Hall KM, Hopkins K, et al. Disability rating scale for severe head trauma: coma to community. Arch Phys Med Rehabil. 1982;63:118-123.
19. Splaingard ML, Gaebler D, Havens PL, Kalichman M. Brain injury: Functional outcome in children with tracheostomies and gastrostomies. Arch Phys Med Rehabil. 1989;70:318-321.
20. Klivenyi P, Ferrante RJ, Matthews RT, et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med. 1999;5:347-350.
21. Lifshitz J, Friberg H, Neumar RW, et al. Structural and functional damage sustained by mitochondria after traumatic brain injury in the rat: evidence for differentially sensitive populations in the cortex and hippocampus. J Cereb Blood Flow Metab. 2003;23:219-231.
22. Borges N, Cerejo A, Santos A, Sarmento A, Azevedo I. Changes in rat cerebral mitochondrial succinate dehydrogenase activity after brain trauma. Int J Neurosci. 2004;114:217-227.
23. Eppenberger-Eberhardt M, Riesinger I, Messerli M, et al. Adult rat cardiomyocytes cultured in creatine-deficient medium display large mitochondria with paracrystalline inclusions, enriched for creatine kinase. J Cell Biol. 1991;113:289-302.
24. Komura K, Hobbiebrunken E, Wilichowski EK, Hanefeld FA. Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies. Pediatr Neurol. 2003;28:53-58.
25. Borchert A, Wilichowski E, Hanefeld F. Supplementation with creatine monohydrate in children with mitochondrial encephalomyopathies. Muscle Nerve. 1999;22:1299-1300.